We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.53B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+28.94%
3 Year Est. Return
+83.96%
5 Year Est. Return
+104.85%
10 Year Est. Return
+351.46%
AUM
$1.45B
AUM Growth
+$80.7M
Cap. Flow
+$52.9M
Cap. Flow %
3.65%
Top 10 Hldgs %
20.47%
Holding
1,274
New
111
Increased
290
Reduced
384
Closed
58

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$4.37M
2
MDT icon
Medtronic
MDT
+$2.83M
3
CVS icon
CVS Health
CVS
+$2.33M
4
NWL icon
Newell Brands
NWL
+$1.75M
5
BABA icon
Alibaba
BABA
+$1.71M

Sector Composition

Rank Sector Weight
1 Miscellaneous 14.91%
2 Industrials 12.55%
3 Healthcare 12.2%
4 Consumer Staples 12.15%
5 Technology 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMR icon
1101
The RMR Group
RMR
$334M
$1K ﹤0.01%
47
+24
+104% +$931
TDC icon
1102
Teradata
TDC
$2.56B
$1K ﹤0.01%
47
CS
1103
DELISTED
Credit Suisse Group
CS
$1K ﹤0.01%
100
-693
-87% -$9.71K
AEGN
1104
DELISTED
Aegion Corp
AEGN
$1K ﹤0.01%
50
AIG.WS
1105
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
48
+3
+7% +$65
JCP
1106
DELISTED
J.C. Penney Company, Inc.
JCP
$1K ﹤0.01%
+85
New +$768
TIME
1107
DELISTED
Time Inc.
TIME
$1K ﹤0.01%
6
GCVRZ
1108
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1K ﹤0.01%
3,004
-1,680
-36% -$569
AGEN
1109
Agenus
AGEN
$354M
$0 ﹤0.01%
12
AIVI icon
1110
WisdomTree International AI Enhanced Value Fund
AIVI
$63.7M
-300
Closed -$12K
APVO icon
1111
Aptevo Therapeutics
APVO
$3.28M
0
ARCC icon
1112
Ares Capital
ARCC
$14.2B
$0 ﹤0.01%
32
AWP
1113
abrdn Global Premier Properties Fund
AWP
$353M
-452
Closed -$8K
BBU
1114
DELISTED
Brookfield Business Partners
BBU
$0 ﹤0.01%
37
BXMX
1115
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
-2,518
Closed -$33K
BYM
1116
DELISTED
BlackRock Municipal Income Quality Trust
BYM
-2,750
Closed -$43K
CC icon
1117
Chemours
CC
$2.33B
$0 ﹤0.01%
40
CII icon
1118
BlackRock Enhanced Captial and Income Fund
CII
$1.06B
$0 ﹤0.01%
29
COKE icon
1119
Coca-Cola Consolidated
COKE
$12.7B
-500
Closed -$7K
CRVL icon
1120
CorVel
CRVL
$3.39B
$0 ﹤0.01%
+30
New +$343
DJP icon
1121
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$882M
-150
Closed -$4K
EBS icon
1122
Emergent Biosolutions
EBS
$309M
$0 ﹤0.01%
30
EFAV icon
1123
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
-225
Closed -$15K
ENB icon
1124
Enbridge
ENB
$111B
-500
Closed -$22K
ERIC icon
1125
Ericsson
ERIC
$32.9B
-1,143
Closed -$8K

Similar funds

Central Trust Company's Q4 2016 Portfolio in Review

As of Q4 2016, Central Trust Company held 1,274 positions worth $1.45B, up 5.9% from $1.37B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Central Trust Company deployed $52.9M of net new capital in Q4 2016, opening 111 new positions and adding to 290 existing holdings. Its largest new stake was PARSLEY ENERGY INC: 57,050 shares worth $2.01M.

By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Allergan plc, an estimated $4.37M trimmed.

  • Central Trust Company's largest Q4 2016 buy was PARSLEY ENERGY INC: 57,050 shares worth $2.01M.
  • Central Trust Company added most to iShares Gold Trust in Q4 2016, an estimated $11.8M increase.
  • Central Trust Company's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $4.37M.
  • Central Trust Company fully exited VEOLIA ENVIRONNEMENT in Q4 2016, selling an estimated $329K.
  • Central Trust Company's ten largest holdings make up 20% of its $1.45B portfolio in Q4 2016.
  • Central Trust Company opened 111 new positions and closed 58 in Q4 2016.
  • Central Trust Company's portfolio value rose 5.9% quarter-over-quarter to $1.45B.

Based on Central Trust Company's 13F filing for Q4 2016, filed 24 Jan 2017.